Form 8-K - Current report:
SEC Accession No. 0001213900-26-077127
Filing Date
2026-07-10
Accepted
2026-07-10 16:02:00
Documents
14
Period of Report
2026-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0297284-8k425_inmed.htm   iXBRL 8-K 42047
2 AMENDMENT NO.1 TO THE AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS ea029728401ex2-2.htm EX-2.2 38730
3 PRESS RELEASE, ISSUED ON JULY 6, 2026 ea029728401ex99-1.htm EX-99.1 21958
4 GRAPHIC ea029728401_ex99-1img1.jpg GRAPHIC 13086
  Complete submission text file 0001213900-26-077127.txt   304566

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inm-20260706.xsd EX-101.SCH 3020
6 XBRL LABEL FILE inm-20260706_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE inm-20260706_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0297284-8k425_inmed_htm.xml XML 3086
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 261168731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)